Published in Medical Letter on the CDC and FDA, July 13th, 2003
The U.S. Food and Drug Administration (FDA) has approved a flu vaccine that is delivered by a squirt up the nose instead of a shot in the arm.
The vaccine, called FluMist (MedImmune Vaccines, Inc.), was approved June 17, 2003, by the FDA for healthy people ages 5 to 49, but not for people who often are in most need of protection from the flu: toddlers, the elderly, and people with asthma or some other chronic diseases.
For children 5 to 8, the first exposure to FluMist requires 2 doses 6 weeks apart. Patients ages 9 to 49 need only 1...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.